Cloud Platform

MyoVista® Insights

Cloud-based AI-enabled ECG Management System that transforms existing ECG infrastructure into an advanced cardiac screening system. Seamless EHR integration and real-time results.

Platform Overview

AI-ECG Analysis Without Hardware Replacement

MyoVista® Insights™ delivers advanced AI-ECG algorithms through your existing ECG devices. Our cloud-based platform processes standard 12-lead ECGs and returns actionable insights within seconds, enabling earlier detection of cardiac conditions that traditional ECGs miss.

Designed for health systems seeking to maximize the clinical value of their current ECG infrastructure, the platform scales from single clinics to enterprise-wide deployments with no processing limits.

MyoVista® Insights™ Platform - AI-ECG Analysis Dashboard
Key Features

Platform Capabilities

Purpose-built for clinical workflows with enterprise-grade security and scalability.

Cloud-Based Analysis

Scalable infrastructure with no processing limits. Analyze thousands of ECGs simultaneously across your entire health system.

Real-Time Results

AI-ECG analysis returned within seconds of ECG upload. Immediate actionable insights at the point of care.

ECG Management

Comprehensive ECG workflow management with advanced filtering, comparison tools, and clinical decision support.

HIPAA Compliant

Enterprise-grade security with end-to-end encryption. Your patient data protected by industry-leading protocols.

Multi-User Access

Role-based permissions for clinicians, administrators, and IT staff. Secure collaboration across departments.

SaaS Model

Pay only for what you use with no upfront capital investment. Automatic updates ensure access to latest algorithms.

Technical Specifications

AI-ECG Prioritization

Access one of the world's largest commercial portfolios of AI-ECG algorithms for clinical triage and prioritization.

Structural Heart Disease

Detect valvular conditions including mitral valve regurgitation and aortic stenosis before symptoms manifest.

Ventricular Function Screening

Screen for reduced and preserved ejection fraction, impaired cardiac relaxation, and other ventricular function markers from standard ECG.

Continuous Innovation

New algorithms added regularly through cloud updates. No hardware changes required to access latest capabilities.

Available Algorithms

Algorithm Portfolio

Pre-FDA Submission

  • Low Ejection Fraction
  • Preserved Ejection Fraction
  • Impaired Cardiac Relaxation

In Development

  • Mitral Valve Regurgitation
  • Aortic Stenosis
  • Pulmonary Embolism
  • Right Ventricle Size & Function
Integration

Seamless EHR Integration

Connect MyoVista® Insights™ to your existing clinical systems with minimal IT overhead.

HL7 FHIR

Native FHIR R4 support for modern EHR connectivity

REST API

Flexible API for custom integrations and workflows

PDF Reports

Automated report generation for clinical documentation

Epic Integration

Epic Toolbox designation for seamless EHR integration

Device Agnostic Platform

MyoVista® Insights™ works with 12-lead ECG devices from major manufacturers including GE Healthcare, Philips, Mortara, Cardioline, Welch Allyn, and Baxter. No proprietary hardware required - leverage your existing ECG infrastructure.

Get Started

Ready to See the Platform?

Request a personalized demo and discover how our AI-ECG platform can enhance your cardiac screening workflow.